Jun Gong

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study

John H. Strickler, Andrea Cercek, Salvatore Siena et al. · The Lancet Oncology · 2023 · 217 citations

Oncology, Medicine, Pathology +7

Response to PD-1 Blockade in Microsatellite Stable Metastatic Colorectal Cancer Harboring a<i>POLE</i>Mutation

Jun Gong, Chongkai Wang, Peter P. Lee et al. · Journal of the National Comprehensive Cancer Network · 2017 · 208 citations · Full text

Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy

Alex B. Blair, Jianxin Wang, John Davelaar et al. · Gastroenterology · 2022 · 69 citations · Full text

Pancreatic Cancer, Medicine, Cell Death +9

Immune profiling of microsatellite instability-high and polymerase ε (POLE)-mutated metastatic colorectal tumors identifies predictors of response to anti-PD-1 therapy

Chongkai Wang, Jun Gong, Travis Y. Tu et al. · Journal of Gastrointestinal Oncology · 2018 · 60 citations · Full text

Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experience

Jun Gong, May Cho, Marvin Sy et al. · Oncotarget · 2017 · 58 citations · Full text